Shopping Cart 0
Cart Subtotal
AED 0

Hologic Inc (HOLX) - Medical Equipment - Deals and Alliances Profile

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Single User License
AED 918

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Site License
AED 1835

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Download Option: Yes
Deliverable Format : Excel, PDF viewable on the website via username

Corporate User License
AED 2753

Details

Summary

Hologic Inc (Hologic) develops, manufactures and supplies diagnostic products, medical imaging systems, surgical products and light-based aesthetic and medical treatment systems. The company offers products to aid in the diagnosis of human diseases; breast imaging and related products and accessories; gynecology surgical products including endometrial ablation system and hysteroscopic tissue removal system; aesthetic laser treatment systems; and skeletal health products including dual-energy X-ray bone densitometry systems and mini C-arm imaging products. The company offers these solutions to surgeons, hospitals, clinical laboratories and healthcare providers. Hologic offers its products and services through direct sales and a network of independent distributors and sales representatives. The company operates in the Americas, Europe and Asia-Pacific. Hologic is headquartered in Marlborough, Massachusetts, the US.

Hologic Inc (HOLX)-Medical Equipment-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 3

List of Tables 5

List of Figures 5

Hologic Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 7

Hologic Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 8

Hologic Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 9

Hologic Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 10

Hologic Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 11

Hologic Inc, Medical Equipment, Deal Details 13

Asset Purchase 13

Hologic Acquires PCA3 Assets from DiagnoCure for USD4.7 Million 13

Venture Financing 14

Focal Therapeutics Raises USD3.8 Million in Venture Financing 14

Focal Therapeutics Raises USD7.8 Million in Venture Financing 15

Private Equity 16

Percipient Capital Completes Management Buyout Of Elucigene Diagnostics 16

Partnerships 17

MeVis Medical Enters into Licensing Agreement with Hologic 17

Cynosure Enters into Distribution Agreement with Porter Instrument 18

Precision X-Ray and Faxitron Bioptics Form DRMC X-Ray 19

Hologic Enters into Agreement with Royal Philips 20

Hologic Enters into Development and Distribution Agreement with Clarius Mobile Health 21

Faxitron Bioptics Enters into Agreement with Health Beacons 22

Seegene Enters into Agreement with Hologic 23

U.S. Department of Health and Human Services Enters into Agreement with Hologic 24

Bovie Medical Enters into Agreement with Hologic 25

Metamark Genetics Enters into Distribution Agreement with Hologic 26

Metamark Genetics Plans to Enter into Co-Development Agreement with Hologic 27

Cynosure Enters into Co-Marketing Agreement with El.En for MonaLisa Touch 28

Medimaps Enters into Distribution Agreement with Hologic for TBS iNsight 29

Devicor Medical Products Enters Into Distribution Agreement With Faxitron Bioptics For CoreVision 30

Quest Diagnostics Enters Into Co-Development Agreement With Hologic 31

Equity Offering 32

Cynosure Completes Public Offering Of Class A Shares For USD 58 Million 32

Debt Offering 33

Hologic Raises USD400 Million in Private Placement of 4.625% Notes Due 2028 33

Hologic Raises USD600 Million in Private Placement of 4.375% Notes Due 2025 34

Hologic Raises USD350 Million in Private Placement of 4.375% Notes Due 2025 35

Hologic Raises USD1 Billion in Private Placement of 5.25% Notes Due 2022 36

Hologic Completes Private Placement Of Senior Notes Due 2020 For USD 1 Billion 37

Asset Transactions 38

Grifols Acquires Nucleic Acid Testing Donor Screening Unit from Hologic for USD1.85 Billion 38

Immucor Completes Acquisition Of Lifecodes Business Of Hologic For USD 95 Million 40

Acquisition 42

Hologic to Acquire Focal Therapeutics for USD125 Million 42

Hologic Acquires Faxitron Bioptics for USD85 Million 43

Hologic Acquires Cynosure in Tender Offer 44

Cynosure Acquires Ellman International for USD13 Million 46

Cynosure Completes Acquisition Of Palomar Medical Technologies For USD 287 Million 47

Hologic Completes Acquisition Of Gen-Probe For USD 3.7 Billion 49

Hologic Inc-Key Competitors 51

Hologic Inc-Key Employees 52

Hologic Inc-Locations And Subsidiaries 53

Head Office 53

Other Locations & Subsidiaries 53

Affiliate 56

Recent Developments 57

Strategy And Business Planning 57

Sep 27, 2018: Hologic to buy Focal Therapeutics for USD 125m 57

Financial Announcements 58

Jul 31, 2018: Hologic Announces Financial Results for Third Quarter of Fiscal 2018 58

May 02, 2018: Hologic Announces Financial Results for Second Quarter of Fiscal 2018 59

Feb 08, 2018: Hologic Announces Financial Results for First Quarter of Fiscal 2018 61

Jan 08, 2018: Hologic Preliminary Revenues Increase 8% to Approximately USD 791 Million in the First Quarter of Fiscal 2018 63

Nov 08, 2017: Hologic Announces Financial Results for Fourth Quarter of Fiscal 2017 64

Aug 02, 2017: Hologic Announces Financial Results for Third Quarter of Fiscal 2017 66

May 10, 2017: Hologic Announces Financial Results for Second Quarter of Fiscal 2017 68

Feb 01, 2017: Hologic Announces Financial Results for First Quarter of Fiscal 2017 69

Corporate Communications 71

Jul 31, 2018: Hologic Announces Chief Financial Officer Change 71

Jan 11, 2018: Namal Nawana Elected to Hologic Board of Directors 72

May 16, 2017: Charles J. Dockendorff Elected to Hologic Board of Directors 73

Jan 04, 2017: Hologic Appoints President of EMEA and Canada, Completing International Leadership Team 74

Legal and Regulatory 75

Aug 01, 2018: US judge finds Fujifilm infringed on Hologic's mammography patents 75

Product News 76

Apr 27, 2018: Leading Women's Health Company Hologic Features Its Innovative Suite of Products at 2018 American College of Obstetricians and Gynecologists Annual Clinical and Scientific Meeting 76

Mar 01, 2017: Hologic to Showcase Groundbreaking Breast Cancer Screening and Interventional Solutions at European Congress of Radiology 2017 78

Appendix 79

Methodology 79

About GlobalData 79

Contact Us 79

Disclaimer 79


List Of Figure

List of Figures

Hologic Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2

Hologic Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2

Hologic Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2

Hologic Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2

Hologic Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 7

Hologic Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 8

Hologic Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 9

Hologic Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 10


List Of Table

List of Tables

Hologic Inc, Medical Equipment, Key Facts, 2017 2

Hologic Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2

Hologic Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 7

Hologic Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 8

Hologic Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 9

Hologic Inc, Deals By Market, 2012 to YTD 2018 10

Hologic Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 11

Hologic Acquires PCA3 Assets from DiagnoCure for USD4.7 Million 13

Focal Therapeutics Raises USD3.8 Million in Venture Financing 14

Focal Therapeutics Raises USD7.8 Million in Venture Financing 15

Percipient Capital Completes Management Buyout Of Elucigene Diagnostics 16

MeVis Medical Enters into Licensing Agreement with Hologic 17

Cynosure Enters into Distribution Agreement with Porter Instrument 18

Precision X-Ray and Faxitron Bioptics Form DRMC X-Ray 19

Hologic Enters into Agreement with Royal Philips 20

Hologic Enters into Development and Distribution Agreement with Clarius Mobile Health 21

Faxitron Bioptics Enters into Agreement with Health Beacons 22

Seegene Enters into Agreement with Hologic 23

U.S. Department of Health and Human Services Enters into Agreement with Hologic 24

Bovie Medical Enters into Agreement with Hologic 25

Metamark Genetics Enters into Distribution Agreement with Hologic 26

Metamark Genetics Plans to Enter into Co-Development Agreement with Hologic 27

Cynosure Enters into Co-Marketing Agreement with El.En for MonaLisa Touch 28

Medimaps Enters into Distribution Agreement with Hologic for TBS iNsight 29

Devicor Medical Products Enters Into Distribution Agreement With Faxitron Bioptics For CoreVision 30

Quest Diagnostics Enters Into Co-Development Agreement With Hologic 31

Cynosure Completes Public Offering Of Class A Shares For USD 58 Million 32

Hologic Raises USD400 Million in Private Placement of 4.625% Notes Due 2028 33

Hologic Raises USD600 Million in Private Placement of 4.375% Notes Due 2025 34

Hologic Raises USD350 Million in Private Placement of 4.375% Notes Due 2025 35

Hologic Raises USD1 Billion in Private Placement of 5.25% Notes Due 2022 36

Hologic Completes Private Placement Of Senior Notes Due 2020 For USD 1 Billion 37

Grifols Acquires Nucleic Acid Testing Donor Screening Unit from Hologic for USD1.85 Billion 38

Immucor Completes Acquisition Of Lifecodes Business Of Hologic For USD 95 Million 40

Hologic to Acquire Focal Therapeutics for USD125 Million 42

Hologic Acquires Faxitron Bioptics for USD85 Million 43

Hologic Acquires Cynosure in Tender Offer 44

Cynosure Acquires Ellman International for USD13 Million 46

Cynosure Completes Acquisition Of Palomar Medical Technologies For USD 287 Million 47

Hologic Completes Acquisition Of Gen-Probe For USD 3.7 Billion 49

Hologic Inc, Key Competitors 51

Hologic Inc, Key Employees 52

Hologic Inc, Other Locations 53

Hologic Inc, Subsidiaries 53

Hologic Inc, Affiliate 56

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products and Companies

Products

Hologic Inc, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.

Company Profile

Company Profile Title

Summary

Hologic Inc (Hologic) develops, manufactures and supplies diagnostic products, medical imaging systems, surgical products and light-based aesthetic and medical treatment systems. The company offers products to aid in the diagnosis of human diseases; breast imaging and related products and accessories; gynecology surgical products including endometrial ablation system and hysteroscopic tissue removal system; aesthetic laser treatment systems; and skeletal health products including dual-energy X-ray bone densitometry systems and mini C-arm imaging products. The company offers these solutions to surgeons, hospitals, clinical laboratories and healthcare providers. Hologic offers its products and services through direct sales and a network of independent distributors and sales representatives. The company operates in the Americas, Europe and Asia-Pacific. Hologic is headquartered in Marlborough, Massachusetts, the US.

Hologic Inc (HOLX)-Medical Equipment-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Scope

Table of Contents

Table of Contents 3

List of Tables 5

List of Figures 5

Hologic Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 7

Hologic Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 8

Hologic Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 9

Hologic Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 10

Hologic Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 11

Hologic Inc, Medical Equipment, Deal Details 13

Asset Purchase 13

Hologic Acquires PCA3 Assets from DiagnoCure for USD4.7 Million 13

Venture Financing 14

Focal Therapeutics Raises USD3.8 Million in Venture Financing 14

Focal Therapeutics Raises USD7.8 Million in Venture Financing 15

Private Equity 16

Percipient Capital Completes Management Buyout Of Elucigene Diagnostics 16

Partnerships 17

MeVis Medical Enters into Licensing Agreement with Hologic 17

Cynosure Enters into Distribution Agreement with Porter Instrument 18

Precision X-Ray and Faxitron Bioptics Form DRMC X-Ray 19

Hologic Enters into Agreement with Royal Philips 20

Hologic Enters into Development and Distribution Agreement with Clarius Mobile Health 21

Faxitron Bioptics Enters into Agreement with Health Beacons 22

Seegene Enters into Agreement with Hologic 23

U.S. Department of Health and Human Services Enters into Agreement with Hologic 24

Bovie Medical Enters into Agreement with Hologic 25

Metamark Genetics Enters into Distribution Agreement with Hologic 26

Metamark Genetics Plans to Enter into Co-Development Agreement with Hologic 27

Cynosure Enters into Co-Marketing Agreement with El.En for MonaLisa Touch 28

Medimaps Enters into Distribution Agreement with Hologic for TBS iNsight 29

Devicor Medical Products Enters Into Distribution Agreement With Faxitron Bioptics For CoreVision 30

Quest Diagnostics Enters Into Co-Development Agreement With Hologic 31

Equity Offering 32

Cynosure Completes Public Offering Of Class A Shares For USD 58 Million 32

Debt Offering 33

Hologic Raises USD400 Million in Private Placement of 4.625% Notes Due 2028 33

Hologic Raises USD600 Million in Private Placement of 4.375% Notes Due 2025 34

Hologic Raises USD350 Million in Private Placement of 4.375% Notes Due 2025 35

Hologic Raises USD1 Billion in Private Placement of 5.25% Notes Due 2022 36

Hologic Completes Private Placement Of Senior Notes Due 2020 For USD 1 Billion 37

Asset Transactions 38

Grifols Acquires Nucleic Acid Testing Donor Screening Unit from Hologic for USD1.85 Billion 38

Immucor Completes Acquisition Of Lifecodes Business Of Hologic For USD 95 Million 40

Acquisition 42

Hologic to Acquire Focal Therapeutics for USD125 Million 42

Hologic Acquires Faxitron Bioptics for USD85 Million 43

Hologic Acquires Cynosure in Tender Offer 44

Cynosure Acquires Ellman International for USD13 Million 46

Cynosure Completes Acquisition Of Palomar Medical Technologies For USD 287 Million 47

Hologic Completes Acquisition Of Gen-Probe For USD 3.7 Billion 49

Hologic Inc-Key Competitors 51

Hologic Inc-Key Employees 52

Hologic Inc-Locations And Subsidiaries 53

Head Office 53

Other Locations & Subsidiaries 53

Affiliate 56

Recent Developments 57

Strategy And Business Planning 57

Sep 27, 2018: Hologic to buy Focal Therapeutics for USD 125m 57

Financial Announcements 58

Jul 31, 2018: Hologic Announces Financial Results for Third Quarter of Fiscal 2018 58

May 02, 2018: Hologic Announces Financial Results for Second Quarter of Fiscal 2018 59

Feb 08, 2018: Hologic Announces Financial Results for First Quarter of Fiscal 2018 61

Jan 08, 2018: Hologic Preliminary Revenues Increase 8% to Approximately USD 791 Million in the First Quarter of Fiscal 2018 63

Nov 08, 2017: Hologic Announces Financial Results for Fourth Quarter of Fiscal 2017 64

Aug 02, 2017: Hologic Announces Financial Results for Third Quarter of Fiscal 2017 66

May 10, 2017: Hologic Announces Financial Results for Second Quarter of Fiscal 2017 68

Feb 01, 2017: Hologic Announces Financial Results for First Quarter of Fiscal 2017 69

Corporate Communications 71

Jul 31, 2018: Hologic Announces Chief Financial Officer Change 71

Jan 11, 2018: Namal Nawana Elected to Hologic Board of Directors 72

May 16, 2017: Charles J. Dockendorff Elected to Hologic Board of Directors 73

Jan 04, 2017: Hologic Appoints President of EMEA and Canada, Completing International Leadership Team 74

Legal and Regulatory 75

Aug 01, 2018: US judge finds Fujifilm infringed on Hologic's mammography patents 75

Product News 76

Apr 27, 2018: Leading Women's Health Company Hologic Features Its Innovative Suite of Products at 2018 American College of Obstetricians and Gynecologists Annual Clinical and Scientific Meeting 76

Mar 01, 2017: Hologic to Showcase Groundbreaking Breast Cancer Screening and Interventional Solutions at European Congress of Radiology 2017 78

Appendix 79

Methodology 79

About GlobalData 79

Contact Us 79

Disclaimer 79


List Of Figure

List of Figures

Hologic Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2

Hologic Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2

Hologic Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2

Hologic Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2

Hologic Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 7

Hologic Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 8

Hologic Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 9

Hologic Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 10


List Of Table

List of Tables

Hologic Inc, Medical Equipment, Key Facts, 2017 2

Hologic Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2

Hologic Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 7

Hologic Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 8

Hologic Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 9

Hologic Inc, Deals By Market, 2012 to YTD 2018 10

Hologic Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 11

Hologic Acquires PCA3 Assets from DiagnoCure for USD4.7 Million 13

Focal Therapeutics Raises USD3.8 Million in Venture Financing 14

Focal Therapeutics Raises USD7.8 Million in Venture Financing 15

Percipient Capital Completes Management Buyout Of Elucigene Diagnostics 16

MeVis Medical Enters into Licensing Agreement with Hologic 17

Cynosure Enters into Distribution Agreement with Porter Instrument 18

Precision X-Ray and Faxitron Bioptics Form DRMC X-Ray 19

Hologic Enters into Agreement with Royal Philips 20

Hologic Enters into Development and Distribution Agreement with Clarius Mobile Health 21

Faxitron Bioptics Enters into Agreement with Health Beacons 22

Seegene Enters into Agreement with Hologic 23

U.S. Department of Health and Human Services Enters into Agreement with Hologic 24

Bovie Medical Enters into Agreement with Hologic 25

Metamark Genetics Enters into Distribution Agreement with Hologic 26

Metamark Genetics Plans to Enter into Co-Development Agreement with Hologic 27

Cynosure Enters into Co-Marketing Agreement with El.En for MonaLisa Touch 28

Medimaps Enters into Distribution Agreement with Hologic for TBS iNsight 29

Devicor Medical Products Enters Into Distribution Agreement With Faxitron Bioptics For CoreVision 30

Quest Diagnostics Enters Into Co-Development Agreement With Hologic 31

Cynosure Completes Public Offering Of Class A Shares For USD 58 Million 32

Hologic Raises USD400 Million in Private Placement of 4.625% Notes Due 2028 33

Hologic Raises USD600 Million in Private Placement of 4.375% Notes Due 2025 34

Hologic Raises USD350 Million in Private Placement of 4.375% Notes Due 2025 35

Hologic Raises USD1 Billion in Private Placement of 5.25% Notes Due 2022 36

Hologic Completes Private Placement Of Senior Notes Due 2020 For USD 1 Billion 37

Grifols Acquires Nucleic Acid Testing Donor Screening Unit from Hologic for USD1.85 Billion 38

Immucor Completes Acquisition Of Lifecodes Business Of Hologic For USD 95 Million 40

Hologic to Acquire Focal Therapeutics for USD125 Million 42

Hologic Acquires Faxitron Bioptics for USD85 Million 43

Hologic Acquires Cynosure in Tender Offer 44

Cynosure Acquires Ellman International for USD13 Million 46

Cynosure Completes Acquisition Of Palomar Medical Technologies For USD 287 Million 47

Hologic Completes Acquisition Of Gen-Probe For USD 3.7 Billion 49

Hologic Inc, Key Competitors 51

Hologic Inc, Key Employees 52

Hologic Inc, Other Locations 53

Hologic Inc, Subsidiaries 53

Hologic Inc, Affiliate 56

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products

Hologic Inc, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.